The multifaceted role of the microenvironment in liver metastasis: Biology and clinical implications

Cancer Research

Volumn 73, Issue 7, 2013, Pages 2031-2043

  Van Den Eynden, Gert G ^a   Majeed, Ali W ^b   Illemann, Martin ^d   Vermeulen, Peter B ^a   Bird, Nigel C ^b   Høyer Hansen, Gunilla ^d   Eefsen, Rikke Løvendahl ^d   Reynolds, Andrew R ^c   Brodt, Pnina ^e,f  

^a Translational Cancer Research Unit   (Belgium)

^b ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^c INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

^e ROYAL VICTORIA HOSPITAL   (Canada)

^f MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; CXCL16 CHEMOKINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; THYMUS AND ACTIVATION REGULATED CHEMOKINE;

CANCER CELL; CANCER GROWTH; CANCER INVASION; CARCINOGENESIS; CELL ACTIVATION; CELL ADHESION; CELL DAMAGE; CELL DEATH; CELL INTERACTION; CELL KILLING; CELL SURVIVAL; COLORECTAL CARCINOMA; CYTOKINE PRODUCTION; CYTOKINE RELEASE; EXTRACELLULAR MATRIX; GROWTH INHIBITION; KUPFFER CELL; LIVER CELL; LIVER CELL CARCINOMA; LIVER METASTASIS; LIVER SINUSOID; NEOVASCULARIZATION (PATHOLOGY); NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; STELLATE CELL; TARGET CELL; TUMOR MICROENVIRONMENT;

HUMANS; LIVER NEOPLASMS; TUMOR MICROENVIRONMENT;

EID: 84875989422     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-12-3931     Document Type: Review

References (117)

1. Oda M, Han JY, Yokomori H. Local regulators of hepatic sinusoidal microcirculation: recent advances. Clin Hemorheol Microcirc 2000; 23:85-94.
2. Virtual Liver. Available from: http://pie.med.utoronto.ca/VLiver/index. htm.
3. Vidal-Vanaclocha F. The Tumor microenvironment at different stages of hepatic metastasis. In: Brodt P, editor. Liver metastasis: biology and clinical management. 1st ed. Dordecht (Netherlands): Springer; 2011. p. 43-87.
4. Kmiec Z. Cooperation of liver cells in health and disease. Adv Anat Embryol Cell Biol 2001;161:1-151.
5. Smedsrød B, Le Couteur D, Ikejima K, Jaeschke H, Kawada N, Naito M, et al. Hepatic sinusoidal cells in health and disease: update from the 14th International Symposium. Liver Int 2009;29: 490-501.
6. Tabaries S, Siegel PM. Breast cancer liver metastasis. In: Brodt P, editor. Liver metastasis: biology and clinical management. 1st ed. Dordecht (Netherlands): Springer; 2011. p. 273-303.
7. Elgadi K, Reichman T, Cleary SP. Evaluation and management of liver metastases from non-gastrointestinal cancer. In: Brodt P, editor. Liver metastasis: biology and clinical management. 1st ed. Dordecht (Netherlands): Springer; 2011. p. 381-99.
8. Haier J, Korb T, Hotz B, Spiegel HU, Senninger N. An intravital model to monitor steps of metastatic tumor cell adhesion within the hepatic microcirculation. J Gastrointest Surg 2003; 7:507-14.
9. Gassmann P, Hemping-Bovenkerk A, Mees ST, Haier J. Metastatic tumor cell arrest in the liver-lumen occlusion and specific adhesion are not exclusive. Int J Colorectal Dis 2009;24:851-8.
10. Wang HH, McIntosh AR, Hasinoff BB, Rector ES, Ahmed N, Nance DM, et al. B16 melanoma cell arrest in the mouse liver induces nitric oxide release and sinusoidal cytotoxicity: a natural hepatic defense against metastasis. Cancer Res 2000;60:5862-9.
11. YanagidaH, Kaibori M, YoshidaH, Habara K, Yamada M, Kamiyama Y, et al. Hepatic ischemia/reperfusion upregulates the susceptibility of hepatocytes to confer the induction of inducible nitric oxide synthase gene expression. Shock 2006;26:162-8.
12. Braet F, Nagatsuma K, Saito M, Soon L, Wisse E, Matsuura T. The hepatic sinusoidal endothelial lining and colorectal liver metastases. World J Gastroenterol 2007;13:821-5.
13. Hehlgans T, Pfeffer K. The intriguing biology of the tumour necrosis factor/tumour necros is factor receptor superfamily: players, rules and the games. Immunology 2005;115:1-20.
14. Balkwill F. Tumour necrosis factor and cancer. Nat Rev Cancer 2009;9:361-71.
15. Ramadori G, Moriconi F, Malik I, Dudas J. Physiology and pathophysiology of liver inflammation, damage and repair. J Physiol Pharmacol 2008;59(Suppl 1):107-17.
16. Bayon LG, Izquierdo MA, Sirovich I, van Rooijen N, Beelen RH, Meijer S. Role of Kupffer cells in arresting circulating tumor cells and controlling metastatic growth in the liver. Hepatology 1996;23: 1224-31.
17. Bouwens L, Jacobs R, Remels L, Wisse E. Natural cytotoxicity of rat hepatic natural killer cells and macrophages against a syngeneic colon adenocarcinoma. Cancer Immunol Immunother 1988;27: 137-41.
18. Vidal-Vanaclocha F. The prometastatic microenvironment of the liver. Cancer Microenviron 2008;1:113-29.
19. + T cells and natural killer cells in cirrhotic livers with hepatitis C may be involved in their susceptibility to hepatocellular carcinoma. Hepatology 2000; 32:962-9.
20. Bertin S, Neves S, Gavelli A, Baqué P, Brossette N, Simoes S, et al. Cellular and molecular events associated with the antitumor response induced by the cytosine deaminase/5-fluorocytosine suicide gene therapy system in a rat liver metastasis model. Cancer Gene Ther 2007;14:858-66.
21. Takehara T, Uemura A, Tatsumi T, Suzuki T, Kimura R, Shiotani A, et al. Natural killer cell-mediated ablation of metastatic livertumors by hydrodynamic injection of IFNa gene to mice. Int J Cancer 2007;120: 1252-60.
22. Pfister K, Radons J, Busch R, Tidball JG, Pfeifer M, Freitag L, et al. Patient survival by Hsp70 membrane phenotype. Cancer 2007;110: 926-35.
23. Jaeschke H, Smith CW. Mechanisms of neutrophil-induced parenchymal cell injury. J Leukoc Biol 1997;61:647-53.
24. Di Carlo E, Forni G, Lollini P, Colombo MP, Modesti A, Musiani P. The intriguing role of polymorphonuclear neutrophils in antitumor reactions. Blood 2001;97:339-45.
25. Kindzelskii AL, Petty HR. Early membrane rupture events during neutrophil-mediated antibody-dependent tumor cell cytolysis. J Immunol 1999;162:3188-92.
26. Spicer J, Brodt P, Ferri LE. Role of inflammation in the early stages of liver metastasis. In: Brodt P, editor. Liver metastasis: biology and clinical management. 1st ed. Dordecht (Netherlands): Springer; 2011. p. 155-85.
27. Bird NC, Mangnall D, Majeed AW. Biology of colorectal liver metastases: a review. J Surg Oncol 2006;94:68-80.
28. Brodt P, Fallavollita L, Bresalier RS, Meterissian S, Norton CR, Wolitzky BA. Liver endothelial E-selectin mediates carcinoma cell adhesion and promotes liver metastasis. Int J Cancer 1997;71: 612-9.
29. Brodt P. Role of the host inflammatory response in colon carcinoma initiation, progression and liver metastasis. In: Beauchemin N, Huot J, editors. Metastasis of colorectal cancer. 1st ed. Dordecht (Netherlands): Springer; 2010. p. 289-319.
30. Bresalier RS, Byrd JC, Brodt P, Ogata S, Itzkowitz SH, Yunker CK. Liver metastasis and adhesion to the sinusoidal endothelium by human colon cancer cells is related to mucin carbohydrate chain length. Int J Cancer 1998;76:556-62.
31. Khatib A-M, Auguste P, Fallavollita L, Wang N, Samani A, Kontogiannea M, et al. Characterization of the host proinflammatory response to tumor cells during the initial stages of liver metastasis. Am J Pathol 2005;167:749-59.
32. Auguste P, Fallavollita L, Wang N, Burnier J, Bikfalvi A, Brodt P. The host inflammatory response promotes liver metastasis by increasing tumor cell arrest and extravasation. Am J Pathol 2007; 170:1781-92.
33. Khatib AM, Kontogiannea M, Fallavollita L, Jamison B, Meterissian S, Brodt P. Rapid induction of cytokine and E-selectin expression in the liver in response to metastatic tumor cells. Cancer Res 1999;59: 1356-61.
34. Khatib A-M, Fallavollita L, Wancewicz EV, Monia BP, Brodt P. Inhibition of hepatic endothelial E-selectin expression by C-raf antisense oligonucleotides blocks colorectal carcinoma liver metastasis. Cancer Res 2002;62:5393-8.
35. Wang N. The secretory leukocyte protease inhibitor is a type 1 insulinlike growth factor receptor-regulated protein that protects against liver metastasis by attenuating the host proinflammatory response. Cancer Res 2006;66:3062-70.
36. Kruskal JB, Azouz A, Korideck H, El-Hallak M, Robson SC, Thomas P, et al. Hepatic colorectal cancer metastases: imaging initial steps of formation in mice. Radiology 2007;243:703-11.
37. Kitakata H, Nemoto-SasakiY, TakahashiY, Kondo T, Mai M, Mukaida N. Essential roles of tumor necrosis factor receptor p55 in liver metastasis of intrasplenic administration of colon 26 cells. Cancer Res 2002;62:6682-7.
38. Soma G, Inagawa H, Fukushima Y, Kanou J, Tomita K, Takano M, et al. Preservation of metastatic ability of colorectal tumor cells stratified by inducibility of endogenous tumor necrosis factor after orthotopic transplantation in nude mice. Anticancer Res 1998;18: 3427-32.
39. Witz IP. The selectin-selectin ligand axis in tumor progression. Cancer Metastasis Rev 2008;27:19-30.
40. Tremblay PL, Huot J, Auger FA. Mechanisms by which E-selectin regulates diapedesis of colon cancer cells under flow conditions. Cancer Res 2008;68:5167-76.
41. Aychek T, Miller K, Sagi-Assif O, Levy-Nissenbaum O, Israeli-Amit M, Pasmanik-Chor M, et al. E-selectin regulates gene expression in metastatic colorectal carcinoma cells and enhances HMGB1 release. Int J Cancer 2008;123:1741-50.
42. Vidal-Vanaclocha F, Fantuzzi G, Mendoza L, Fuentes AM, Anasagasti MJ, Martín J, et al. IL-18 regulates IL-1beta-dependent hepatic melanoma metastasis via vascular cell adhesion molecule-1. Proc Natl Acad Sci U S A 2000;97:734-9.
43. Ye C, Kiriyama K, Mistuoka C, Kannagi R, Ito K, Watanabe T, et al. Expression of E-selectin on endothelial cells of small veins in human colorectal cancer. Int J Cancer 1995;61:455-60.
44. Alexiou D, Karayiannakis AJ, Syrigos KN, Zbar A, Kremmyda A, Bramis I, et al. Serum levels of E-selectin, ICAM-1 and VCAM-1 in colorectal cancer patients: correlations with clinicopathological features, patient survival and tumour surgery. Eur J Cancer 2001; 37:2392-7.
45. Hoff SD, Matsushita Y, Ota DM, Cleary KR, Yamori T, Hakomori S, et al. Increased expression of sialyl-dimeric LeX antigen in liver metastases of human colorectal carcinoma. Cancer Res 1989;49 (24 Pt 1):6883-8.
46. Krause T, Turner GA. Are selectins involved in metastasis? Clin Exp Metastasis 1999;17:183-92.
47. Chen WS, Wei SJ, Liu JM, Hsiao M, Kou-Lin J, Yang WK. Tumor invasiveness and liver metastasis of colon cancer cells correlated with cyclooxygenase-2 (COX-2) expression and inhibited by a COX-2-selective inhibitor, etodolac. Int J Cancer 2001;91: 894-9.
48. Spicer JD, McDonald B, Cools-Lartigue JJ, Chow SC, Giannias B, Kubes P, et al. Neutrophils promote liver metastasis via Mac-1-mediated interactions with circulating tumor cells. Cancer Res 2012;72:3919-27.
49. Yamamoto M, Kikuchi H, Ohta M, Kawabata T, Hiramatsu Y, Kondo K, et al. TSU68 prevents liver metastasis of colon cancer xenografts by modulating the premetastatic niche. Cancer Res 2008;68: 9754-62.
50. Fox-Robichaud A, Kubes P. Molecular mechanisms of tumor necrosis factora-stimulated leukocyte recruitment into the murine hepatic circulation. Hepatology 2000;31:1123-7.
51. Noel A, Jost M, Maquoi E. Matrix metalloproteinases at cancer tumor-host interface. Semin Cell Dev Biol 2008;19:52-60.
52. Thomas P, Forse RA, Bajenova O. Carcinoembryonic antigen (CEA) and its receptor hnRNP M are mediators of metastasis and the inflammatory response in the liver. Clin Exp Metastasis 2011;28: 923-32.
53. Paschos KA, Majeed AW, Bird NC. Role of Kupffer cells in the outgrowth of colorectal cancer liver metastases. Hepatol Res 2010;40:83-94.
54. Ali S, Lazennec G. Chemokines: novel targets for breast cancer metastasis. Cancer Metastasis Rev 2007;26:401-20.
55. Kim J. Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival. J Clin Oncol 2004;23:2744-53.
56. Murakami T, Kawada K, Iwamoto M, Akagami M, HidaK, Nakanishi Y, et al. The role of CXCR3 and CXCR4 in colorectal cancer metastasis. Int J Cancer 2013;132:276-87.
57. Ottaiano A, Franco R, Aiello Talamanca A, Liguori G, Tatangelo F, Delrio P, et al. Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients. Clin Cancer Res 2006;12:2795-803.
58. Fulton AM. The chemokine receptors CXCR4 and CXCR3 in cancer. Curr Oncol Rep 2009;11:125-31.
59. Gassmann P, Haier J, Schlüter K, Domikowsky B, Wendel C, Wiesner U, et al. CXCR4 regulates the early extravasation of metastatic tumor cells in vivo. Neoplasia 2009;11:651-61.
60. Matsusue R, Kubo H, Hisamori S, Okoshi K, Takagi H, Hida K, et al. Hepatic stellate cells promote liver metastasis of colon cancer cells by the action of SDF-1/CXCR4 axis. Ann Surg Oncol 2009;16: 2645-53.
61. Babu SN, Chetal G, Kumar S. Macrophage migration inhibitory factor: a potential marker for cancer diagnosis and therapy. Asian Pac J Cancer Prev 2012;13:1737-44.
62. He X-X, Chen K, Yang J, Li X-Y, Gan H-Y, Liu C-Y, et al. Macrophage migration inhibitory factor promotes colorectal cancer. Mol Med 2009;15:1-10.
63. Ghadjar P, Coupland SE, Na I-K, Noutsias M, Letsch A, Stroux A, et al. Chemokine receptor CCR6 expression level and liver metastases in colorectal cancer. J Clin Oncol 2006;24:1910-6.
64. Shimizu Y. CC-chemokine receptor 6 and its ligand macrophage inflammatory protein 3a might be involved in the amplification of local necroinflammatory response in the liver. Hepatology 2001; 34:311-9.
65. Rubie C, Oliveira V, Kempf K, Wagner M, Tilton B, Rau B, et al. Involvement of chemokine receptor CCR6 in colorectal cancer metastasis. Tumour Biol 2006;27:166-74.
66. Kawamura M, Toiyama Y, Tanaka K, Saigusa S, Okugawa Y, Hiro J, et al. CXCL5, a promoter of cell proliferation, migration and invasion, is a novel serum prognostic marker in patients with colorectal cancer. Eur J Cancer 2012;48:2244-51.
67. Speetjens FM, Kuppen PJK, Sandel MH, Menon AG, Burg D, van de Velde CJH, et al. Disrupted expression of CXCL5 in colorectal cancer is associated with rapid tumor formation in rats and poor prognosis in patients. Clin Cancer Res 2008;14:2276-84.
68. Bailey C, Negus R, Morris A, Ziprin P, Goldin R, Allavena P, et al. Chemokine expression is associated with the accumulation of tumour associated macrophages (TAMs) and progression in human colorectal cancer. Clin Exp Metastasis 2007;24:121-30.
69. Hu H, Sun L, Guo C, Liu Q, Zhou Z, Peng L, et al. Tumor cell-microenvironment interaction models coupled with clinical validation reveal CCL2 and SNCG as two predictors of colorectal cancer hepatic metastasis. Clin Cancer Res 2009;15:5485-93.
70. Hojo S, Koizumi K, Tsuneyama K, Arita Y, Cui Z, Shinohara K, et al. High-level expression of chemokine CXCL16 by tumor cells correlates with a good prognosis and increased tumor-infiltrating lymphocytes in colorectal cancer. Cancer Res 2007;67:4725-31.
71. Kanagawa N, Niwa M, Hatanaka Y, Tani Y, Nakagawa S, Fujita T, et al. CC-chemokine ligand 17 gene therapy induces tumor regression through augmentation of tumor-infiltrating immune cells in a murine model of preexisting CT26 colon carcinoma. Int J Cancer 2007;121: 2013-22.
72. Koizumi K, Hojo S, Akashi T, Yasumoto K, Saiki I. Chemokine receptors in cancer metastasis and cancer cell-derived chemokines in host immune response. Cancer Sci 2007;98:1652-8.
73. Kawada K, Hasegawa S, Murakami T, Itatani Y, Hosogi H, Sonoshita M, et al. Molecular mechanisms of liver metastasis. Int J Clin Oncol 2011;16:464-72.
74. Kaplan RN, Rafii S, Lyden D. Preparing the "soil": the premetastatic niche. Cancer Res 2006;66:11089-93.
75. Peinado H, Aleckovic M, Lavotshkin S, Matei I, Costa-Silva B, Moreno-Bueno G, et al. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat Med 2012;18:883-91.
76. Kaplan RN, Riba RD, Zacharoulis S, Bramley AH, Vincent L, Costa C, et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 2005;438: 820-7.
77. HiratsukaS, DudaDG, Huang Y, Goel S, SugiyamaT, NagasawaT, et al. C-X-C receptor type 4 promotes metastasis by activating p38 mitogen-activated protein kinase in myeloid differentiation antigen (Gr-1)-positive cells. Proc Natl Acad Sci USA 2011;108: 302-7.
78. Ugel S, Delpozzo F, Desantis G, Papalini F, Simonato F, Sonda N, et al. Therapeutic targeting of myeloid-derived suppressor cells. Curr Opin Pharmacol 2009;9:470-81.
79. Younos I, Donkor M, Hoke T, Dafferner A, Samson H, Westphal S, et al. Tumor- and organ-dependent infiltration by myeloid-derived suppressor cells. Int Immunopharmacol 2011;11:816-26.
80. Connolly MK, Mallen-St Clair J, Bedrosian AS, Malhotra A, Vera V, Ibrahim J, et al. Distinct populations of metastases-enabling myeloid cells expand in the liver of mice harboring invasive and preinvasive intra-abdominal tumor. J Leukoc Biol 2010;87:713-25.
81. Kitamura T, Fujishita T, Loetscher P, Revesz L, Hashida H, Kizaka-Kondoh S, et al. Inactivation of chemokine (C-C motif) receptor 1 (CCR1) suppresses colon cancer liver metastasis by blocking accumulation of immature myeloid cells in a mouse model. Proc Natl Acad Sci U S A 2010;107:13063-8.
82. Arabzadeh A, Chan C, Nouvion A-L, Breton V, Benlolo S, Demarte L, et al. Host-related carcinoembryonic antigen cell adhesion molecule 1 promotes metastasis of colorectal cancer. Oncogene 2013;32: 849-60.
83. Zhao L, Lim SY, Gordon-Weeks AN, TapmeierTT, Im JH, Cao Y, et al. Recruitment of a myeloid cell subset (CD11b/Gr1(mid))via CCL2/CCR2 promotes thedevelopment of colorectal cancer liver metastasis. Hepatology 2013;57:829-39.
84. Friedman SL Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev 2008;88:125-72.
85. Wirz W, Antoine M, Tag CG, Gressner AM, Korff T, Hellerbrand C, et al. Hepatic stellate cells display a functional vascular smooth muscle cell phenotype in a three-dimensional co-culture model with endothelial cells. Differentiation 2008;76:784-94.
86. Friedman SL. Mechanisms of hepatic fibrogenesis. Gastroenterology 2008;134:1655-69.
87. Burnier JV, Wang N, Michel RP, Hassanain M, LiS, Lu Y, et al. Type IV collagen-initiated signals provide survival and growth cues required for liver metastasis. Oncogene 2011;30:3766-83.
88. Yang X, Lu P, Ishida Y, Kuziel WA, Fujii C, Mukaida N. Attenuated liver tumor formation in the absence of CCR2 with a concomitant reduction in the accumulation of hepatic stellate cells, macrophages and neovascularization. Int J Cancer 2006;118:335-45.
89. Kisseleva T, Brenner DA. The phenotypic fate and functional role for bone marrow-derived stem cells in liver fibrosis. J Hepatol 2012;56: 965-72.
90. Mueller L, Goumas FA, Affeldt M, Sandtner S, Gehling UM, Brilloff S, et al. Stromal fibroblasts in colorectal liver metastases originate from resident fibroblasts and generate an inflammatory microenvironment. Am J Pathol 2007;171:1608-18.
91. Novosyadlyy R, Tron K, Dudas J, Ramadori G, Scharf J-G. Expression and regulation of the insulin-like growth factor axis components in rat liver myofibroblasts. J Cell Physiol 2004;199: 388-98.
92. Long L, Nip J, Brodt P. Paracrine growth stimulation by hepatocyte-derived insulin-like growth factor-1: a regulatory mechanism for carcinoma cells metastatic to the liver. Cancer Res 1994;54: 3732-7.
93. YakarS, Leroith D, Brodt P. The role of the growth hormone/insulinlike growth factor axis in tumor growth and progression: lessons from animal models. Cytokine Growth Factor Rev 2005;16:407-20.
94. Terayama N, Terada T, Nakanuma Y. Histologic growth patterns of metastatic carcinomas of the liver. Jpn J Clin Oncol 1996;26:24-9.
95. Vermeulen PB, Colpaert C, Salgado R, Royers R, Hellemans H, Van Den Heuvel E, et al. Liver metastases from colorectal adenocarcinomas grow in three patterns with different angiogenesis and desmoplasia. J Pathol 2001;195:336-42.
96. Eefsen R, Van den Eynden G, Høyer-Hansen G, Brodt P, Laerum O, Vermeulen P, et al. Histopathological growth pattern, proteolysis and angiogenesis in chemonaive patients resected for multiple colorectal liver metastases. J Oncol 2012;2012:907971.
97. Van den Eynden GG, Bird NC, Majeed AW, Van Laere S, Dirix LY, Vermeulen PB. The histological growth pattern of colorectal cancer liver metastases has prognostic value. Clin Exp Metastasis 2012;29: 541-9.
98. Eefsen R, Van den Eynden G, Brodt P, Burnier J, Høyer-Hansen G, Laerum O, et al. Multiple liver metastases from the same patient exhibit a uniform growth pattern. ASCO GI-Symposium; 2012 Jan 19-21; San Francisco, CA. Abstract nr 87702.
99. Stessels F, Van den Eynden G, Van der Auwera I, Salgado R, Van Den Heuvel E, Harris AL, et al. Breast adenocarcinoma liver metastases, in contrast to colorectal cancer liver metastases, display a non-angiogenic growth pattern that preserves the stroma and lacks hypoxia. Br J Cancer 2004;90:1429-36.
100. Okano K, Yamamoto J, Kosuge T, Yamamoto S, Sakamoto M, Nakanishi Y, et al. Fibrous pseudocapsule of metastatic liver tumors from colorectal carcinoma. Clinicopathologic study of 152 first resection cases. Cancer 2000;89:267-75.
101. Lunevicius R, Nakanishi H, Ito S, Kozaki K, Kato T, Tatematsu M, et al. Clinicopathological significance of fibrotic capsule formation around liver metastasis from colorectal cancer. J Cancer Res Clin Oncol 2001;127:193-9.
102. Dvorak HF. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 1986;315:1650-9.
103. Oike Y, Yasunaga K, Suda T. Angiopoietin-related/angiopoietin-like proteins regulate angiogenesis. Int J Hematol 2004;80:21-8.
104. Dezso K, Bugyik E, Papp V, Lâszlo V, Dome B, Tovari J, et al. Development of arterial blood supply in experimental liver metastases. Am J Pathol 2009;175:835-43.
105. Dome B, Hendrix MJC, Paku S, Tovari J, Tímár J. Alternative vascularization mechanisms in cancer: pathology and therapeutic implications. Am J Pathol 2007;170:1-15.
106. Paku S, Kopper L, Nagy P. Development of the vasculature in "pushing-type" liver metastases of an experimental colorectal cancer. Int J Cancer 2005;115:893-902.
107. Paku S, Lapis K. Morphological aspects of angiogenesis in experimental liver metastases. Am J Pathol 1993;143:926-36.
108. Terayama N, Terada T, Nakanuma Y. An immunohistochemical study of tumourvessels in metastatic liver cancers and the surrounding liver tissue. Histopathology 1996;29:37-43.
109. Yamaguchi J, Komuta K, Matsuzaki S, Okudaira S, Fujioka H, Kanematsu T. Mode of infiltrative growth of colorectal liver metastases is a useful predictor of recurrence after hepatic resection. World J Surg 2002;26:1122-5.
110. Terayama N, Terada T, Nakanuma Y. A morphometric and immunohistochemical study on angiogenesis of human metastatic carcinomas of the liver. Hepatology 1996;24:816-9.
111. Breedis C, Young G. The blood supply of neoplasms in the liver. Am J Pathol 1954;30:969-77.
112. Jögi A, Pass J, Høyer-Hansen G, Lund LR, Nielsen BS, Danø K, et al. Systemic administration of anti-urokinase plasminogen activator receptor monoclonal antibodies induces hepatic fibrin deposition in tissue-type plasminogen activator deficient mice. J Thromb Haemost 2007;5:1936-44.
113. Illemann M, Bird N, Majeed A, Laerum OD, Lund LR, Danø K, et al. Two distinct expression patterns of urokinase, urokinase receptor and plasminogen activator inhibitor-1 in colon cancer liver metastases. Int J Cancer 2009;124:1860-70.
114. Illemann M, Bird N, Majeed A, Sehested M, Laerum OD, Lund LR, et al. MMP-9 is differentially expressed in primary human colorectal adenocarcinomas and their metastases. Mol Cancer Res 2006;4: 293-302.
115. Poulsom R, Pignatelli M, Stetler-Stevenson WG, Liotta LA, Wright PA, Jeffery RE, et al. Stromal expression of 72 kda type IV collagenase (MMP-2) and TIMP-2 mRNAs in colorectal neoplasia. Am J Pathol 1992;141:389-96.
116. Ritsma L, Steller EJA, Beerling E, Loomans CJM, Zomer A, Gerlach C, et al. Intravital microscopy through an abdominal imaging window reveals a pre-micrometastasis stage during liver metastasis. Sci Transl Med 2012;4:158ra145.
117. Allinen M, Beroukhim R, Cai L, Brennan C, Lahti-Domenici J, Huang H, et al. Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell 2004;6: 17-32.